← Back to Search
'On‐off' Phenomenon In Parkinson's Disease
T. Eriksson, A. Granérus, A. Linde, A. Carlsson
Published 1988 · Medicine
Save to my Library
Download via 🐼 PaperPanda Download via oaDOI Download via OAB Download via LibKey Download via Google Google ScholarAnalyze on Scholarcy Visualize in Litmaps
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Administration of a low-protein diet to parkinsonian patients with “on-off” syndromes consistently increased the total daily time of “on” states when compared with a high-protein diet. The clinical effect of the low-protein diet may be due to a marked decrease in the plasma concentration of large neutral amino acids that compete with L-dopa for carrier-mediated transport into the brain.
This paper references
A. Woods (1973)
Sustained-release levodopa. Lancet 1973;1:1391
AC Woods (1973)
“On‐off” phenomenon with levodopa therapy in parkinsonism
S. Fahn (1974)
Plasma dopa concentrations and the “on‐off” effect after chronic treatment of Parkinson's disease
R. Sweet (1974)
The clinical physiology of side effects in long-term L-DOPA therapy.
A. Barbeau (1974)
Variations in the "on-off" effect.
M. Yahr (1974)
The "on-off" response to chronic L-DOPA treatment of Parkinsonism.
R. Sweet (1974)
Variations in the “on-off
Protein intake and treatment of Parkinson's disease with levodopa.
I. Mena (1975)
Patterns of clinical reaponse and plaema dopa levels in Parkinson’s disease
ES Toloea (1975)
Levodopa‐Induced dopamine receptor hypersensitivity
Harold L. Klawans (1977)
Regulation of amino acid availability to the brain
W. Pardridge (1977)
GABA receptor binding in the parkinsonian brain.
U. Rinne (1978)
Factors influencing the occurrence of "on-off" symptoms during long-term treatment with L-dopa.
A. Granérus (1978)
Receptor basis for dopaminergic supersensitivity in Parkinson's disease
T. Lee (1978)
Hornykiewicz 0. Receptor basis for dopaminergic supersensitivity in Parkinson's dieeaee
T Lee (1978)
BRAIN TISSUE AND PLASMA ASSAY OF L‐DOPA AND α‐METHYLDOPA METABOLITES BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY WITH ELECTROCHEMICAL DETECTION
C. Freed (1979)
Parkinson's disease: current progress, problems and management
C D Maraden (1980)
On-off’ phenomena in Parkinson’s dieeaee
CD Maraden (1980)
Behavioural and biochemical changes following chronic administration of L-dopa to rats.
C. Pycock (1982)
Role of precursor availability in control of monoamine biosynthesis in brain.
J. Fernstrom (1983)
Are "on-off" effects during chronic L-dopa treatment due to faulty feedback control of the nigrostriatal dopamine pathway?
A. Carlsson (1983)
Problems associated with long‐term levodopa treatment of Parkinson's disease
U. Rinne (1983)
‘On—off’ effects: the new challenge in parkinsonism
P. Lewitt (1983)
This paper is referenced by
Exploring the Role of Nutraceuticals in Major Depressive Disorder (MDD): Rationale, State of the Art and Future Prospects
M. A. Alvarez-Mon (2021)
Contributions of Gut Bacteria and Diet to Drug Pharmacokinetics in the Treatment of Parkinson's Disease
S. V. Kessel (2019)
Nanoemulsion formulation of florfenicol improves bioavailability in pigs.
Q. Zhang (2016)
Motor fluctuations due to interaction between dietary protein and levodopa in Parkinson’s disease
T. Virmani (2016)
Current practice in nutrition diagnosis and intervention for the management of Parkinson's disease in Australia and Canada
J. Sheard (2015)
Application of monodirectional Janus patch to oromucosal delivery system.
J. B. You (2015)
A Plant-Food Diet in the Risk and Management of Parkinson’s Disease
Luciana Baroni (2015)
Trends in Managing Parkinson’s Disease - A Review
Sm Rashid Hilaly (2014)
Ensuring good nutritional status in patients with Parkinson's disease: challenges and solutions
L. Baroni (2014)
Characterisation of embryonic ventral mesencephalon grafts in a rat model of Parkinson’s disease
M. Fjodorova (2013)
Pharmacokinetic characteristics of capsaicin-loaded nanoemulsions fabricated with alginate and chitosan.
A. Choi (2013)
Neuroleptic Malignant Syndrome Associated With the Use of Carbidopa/Levodopa for Dystonia in Persons With Cerebral Palsy
D. Perry (2012)
Enfermedad de Parkinson
L. Toledo (2012)
L. Schmidt (2012)
Low‐protein and protein‐redistribution diets for Parkinson's disease patients with motor fluctuations: A systematic review
E. Cereda (2010)
Dynamic models with quantized output for modeling patient response to pharmacotherapy
M. Bjork (2010)
Drug–Nutrient Interactions in the Elderly
B. Kinosian (2009)
Effects of Specific Foods and Dietary Components on Drug Metabolism
K. Anderson (2009)
Pharmacokinetic evaluation and modeling of formulated levodopa intranasal delivery systems.
Tae Kyung Kim (2009)
Efeito de uma Intervenção Nutricional em Doentes de Parkinson submetidos a Cirurgia de Estimulação Cerebral Profunda Effect of a Nutritional Intervention on Parkinson's Disease Patients after Deep Brain Stimulation Surgery
Eduarda Filipa (2008)
Effects of a NR2B selective NMDA glutamate antagonist, CP‐101,606, on dyskinesia and parkinsonism
John G. Nutt (2008)
Duodenal levodopa infusion for the treatment of Parkinson’s disease
J. Samanta (2007)
Literature-Related Discovery (LRD)
R. Kostoff (2007)
Movement patterns of peak-dose levodopa-induced dyskinesias in patients with Parkinson's disease
Jackie Gour (2007)
Chapter 50 Pain in Parkinson's disease.
G. Wasner (2006)
Food Habits and Intake of Nutrients in Elderly Patients with Parkinson’s Disease
B. Lorefält (2006)
The levodopa wearing-off phenomenon in Parkinson’s disease: pharmacokinetic considerations
F. Stocchi (2006)
The impact of drug-induced dyskinesias on rapid alternating movements in patients with Parkinson's disease
M. Ghassemi (2005)
Advances in the delivery of treatments for Parkinson’s disease
T. Johnston (2005)
Other pharmacological treatments for motor complications and dyskinesias
C. Waters (2005)
Ambulatory accelerometry in Parkinson's disease
J. Hoff (2005)
Interacciones entre los alimentos y las estatinas
S. D. Andrés (2004)See more